Gema
Fruhbeck Martínez
Consultora Médica
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (9)
2022
-
Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study
Nutrients, Vol. 14, Núm. 1
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
COVID Isolation Eating Scale (CIES): Analysis of the impact of confinement in eating disorders and obesity—A collaborative international study
European Eating Disorders Review
-
Liver CPT1A gene therapy reduces diet-induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD
FASEB Journal, Vol. 34, Núm. 9, pp. 11816-11837
2019
-
Cytoskeletal transgelin 2 contributes to gender-dependent adipose tissue expandability and immune function
FASEB Journal, Vol. 33, Núm. 8, pp. 9656-9671
2014
-
Loss of control over eating: A description of the eating disorder/obesity spectrum in women
European Eating Disorders Review, Vol. 22, Núm. 1, pp. 25-31
2013
-
A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction
Diabetologia, Vol. 56, Núm. 11, pp. 2524-2537
-
Iron and Obesity Status-Associated Insulin Resistance Influence Circulating Fibroblast-Growth Factor-23 Concentrations
PLoS ONE, Vol. 8, Núm. 3
2012
-
Differential insulin receptor substrate-1 (IRS1)-related modulation of neuropeptide y and proopiomelanocortin expression in nondiabetic and diabetic IRS2 -/- mice
Endocrinology, Vol. 153, Núm. 3, pp. 1129-1140